Vault-13

ADDEX THERAPEUTICS LTD ADXN

SPONSORED ADS · ADR · CUSIP 00654J206

Swiss public company

2 institutional holders -2 vs Q4 2023
390390 shares reported held*
$5.0kreported value*
1 new 0 added 0 reduced 3 sold out net sold ≈ $2.0m (-159.4k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.80.

Trends to Q1 2024

Institutional holders

Managers reporting a position, each quarter

024Q4 23: 4Q1 24: 22Q4 23Q1 24
Numbers
QuarterHolders
Q4 20234
Q1 20242

Biggest buyers

Biggest sellers

J. Stern & Co. LLP Sold out -107,827-107.8k
ARMISTICE CAPITAL, LLC Sold out -43,000-43.0k
NEA Management Company, LLC Sold out -9,000-9.0k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Dyer Timothy Mark 13D · may seek influence no change · filed 2026-09-04
Stated purposeThe Reporting Person acquired the securities of the Issuer at founding, through the exercise of options, acquisitions through participation in private placements and in consideration for his services as Chief Executive Officer of the Issuer. The reporting person also received shares issuable upon exercise of options. The terms of the Reporting Person's employment arrangements for 2025 were set forth in the Issuer's Annual Report on Form 20-F for such period filed by the Issuer with the Securities and Exchange Commission on May 15, 2026. Except in respect of such employment arrangements as set forth therein, the Reporting Person does not have any present plans which relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of… Full filing
9.0% no change 19.2m 2026-09-04

Insider purchases and sales in Q1 2024

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q1 2024.

Holders, Q1 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 ADAR1 Capital Management, LLC 0.00% of their portfolio AUSTIN, TX 390390 $5.0k $5.0k 0.00% New
2 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged